Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Robertson

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Australasian Journal of Dermatology|January 19, 2016
Heterogeneity of blastomycosis-like pyoderma: A selection of cases from the last 35 yearsSalvatore Scuderi, Blake O'Brien, Ivan Robertson, et al.
The Australasian Journal of Dermatology|October 17, 2019
Enoxaparin-induced bullous haemorrhagic dermatosisYolanka Lobo, Ivan Robertson, Anne Stewart, et al.
JAAD Case Reports|June 17, 2021
A case of disseminated cryptococcal disease after Bruton tyrosine kinase inhibitor therapy: A brief review in the Australian contextNicholas Van Rooij, Jesse Johnston, Rohan Mortimore, et al.
The Australasian Journal of Dermatology|March 6, 2014
Warfarin-induced erythrodermaCasey J Rowe, Ivan Robertson, Daniel James, et al.
The Australasian Journal of Dermatology|February 18, 2015
Acute cutaneous graft-versus-host disease resembling type II (atypical adult) pityriasis rubra pilarisDevita Surjana, Ivan Robertson, Glen Kennedy, et al.
The Australasian Journal of Dermatology|February 25, 2026
A 10-Year Retrospective Cohort Study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at the Royal Brisbane and Women's HospitalThomas Pagliaro, Gregory Butler, Amanda Godbolt, et al.
Experimental Dermatology|December 10, 2013
Origin of Langerhans cells in normal skin and chronic GVHD after hematopoietic stem-cell transplantationRafiq Andani, Ivan Robertson, Kelli P A Macdonald, et al.
The World Allergy Organization Journal|August 30, 2024
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptionsFiona James, Michelle S Goh, Sara Vogrin, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Australasian Journal of Dermatology|January 19, 2016
Heterogeneity of blastomycosis-like pyoderma: A selection of cases from the last 35 yearsSalvatore Scuderi, Blake O'Brien, Ivan Robertson, et al.
The Australasian Journal of Dermatology|October 17, 2019
Enoxaparin-induced bullous haemorrhagic dermatosisYolanka Lobo, Ivan Robertson, Anne Stewart, et al.
JAAD Case Reports|June 17, 2021
A case of disseminated cryptococcal disease after Bruton tyrosine kinase inhibitor therapy: A brief review in the Australian contextNicholas Van Rooij, Jesse Johnston, Rohan Mortimore, et al.
The Australasian Journal of Dermatology|March 6, 2014
Warfarin-induced erythrodermaCasey J Rowe, Ivan Robertson, Daniel James, et al.
The Australasian Journal of Dermatology|February 18, 2015
Acute cutaneous graft-versus-host disease resembling type II (atypical adult) pityriasis rubra pilarisDevita Surjana, Ivan Robertson, Glen Kennedy, et al.
The Australasian Journal of Dermatology|February 25, 2026
A 10-Year Retrospective Cohort Study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at the Royal Brisbane and Women's HospitalThomas Pagliaro, Gregory Butler, Amanda Godbolt, et al.
Experimental Dermatology|December 10, 2013
Origin of Langerhans cells in normal skin and chronic GVHD after hematopoietic stem-cell transplantationRafiq Andani, Ivan Robertson, Kelli P A Macdonald, et al.
The World Allergy Organization Journal|August 30, 2024
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptionsFiona James, Michelle S Goh, Sara Vogrin, et al.
Pageof 2